Valar Labs Announces $22 Million Series A to Advance Vesta, First AI Diagnostic Test to Predict Treatment Response in Bladder Cancer, and Catalyze Expansion in Other Cancers
Valar Labs
Media Resources
We warmly welcome the interest of reporters in our firm and the companies we support: we’re also happy simply to help journalists working on stories in deep tech.
To reach us, email press@dcvc.com.
Press Releases
39
Avicenna Introduces Machine Learning-Enhanced Medicinal Chemistry Platform to Accelerate the Last Mile of Small Molecule Drug Discovery
Avicenna Biosciences
Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing
Latus Bio
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm
Relation